Literature DB >> 9201206

Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes.

G D Braatvedt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9201206

Source DB:  PubMed          Journal:  N Z Med J        ISSN： 0028-8446


× No keyword cloud information.
  5 in total

1.  Toxicology case of the month: oral hypoglycaemic overdose.

Authors:  J Soderstrom; L Murray; F F S Daly; M Little
Journal:  Emerg Med J       Date:  2006-07       Impact factor: 2.740

Review 2.  Octreotide's role in the management of sulfonylurea-induced hypoglycemia.

Authors:  Patrick P Dougherty; Wendy Klein-Schwartz
Journal:  J Med Toxicol       Date:  2010-06

3.  Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.

Authors:  Paul I Pelavin; Erika Abramson; Steven Pon; Maria G Vogiatzi
Journal:  J Pediatr Endocrinol Metab       Date:  2009-02       Impact factor: 1.634

Review 4.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

Review 5.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.